TPB Wealth Advisors’s Pfizer PFE Stock Holding History

TPB Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,999	Closed	-$205K	–	45
2022 Q4	$205K	Buy	+3,999	New	+$192K	0.11%	46
2022 Q3	–	Sell	-4,894	Closed	-$256K	–	48
2022 Q2	$256K	Buy	4,894 +882	+22%	+$44.9K	0.12%	45
2022 Q1	$208K	Hold	4,012	–	–	0.08%	43
2021 Q4	$237K	Buy	+4,012	New	+$199K	0.12%	45

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TPB Wealth Advisors's PFE Position: Q1 2023 in Review

TPB Wealth Advisors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 3,999 shares — an estimated $205K sold.

TPB Wealth Advisors first reported a position in PFE in Q4 2021 and held it in 4 quarters. The position peaked at $256K in Q2 2022. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

TPB Wealth Advisors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
TPB Wealth Advisors sold 3,999 Pfizer shares in Q1 2023, an estimated $205K.
TPB Wealth Advisors first reported a position in Pfizer in Q4 2021 and held it in 4 quarters.
TPB Wealth Advisors's Pfizer position peaked at $256K in Q2 2022.
3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on TPB Wealth Advisors's 13F filing for Q1 2023, filed 23 May 2023.